Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Hepatology (Baltimore, Md.)|September 9, 2024
Efficacy and safety of infliximab in patients with autoimmune hepatitisCumali Efe, Ellina Lytvyak, Tuğçe Eşkazan, et al.
The American Journal of Gastroenterology|June 27, 2019
Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary CholangitisCumali Efe, Koray Taşçilar, Ida Henriksson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 19, 2020
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing CholangitisCharlotte Rose Hawkey Hedin, Gina Sado, Nelson Ndegwa, et al.
The Journal of Headache and Pain|July 17, 2025
Hallmarks of primary headache: part 2- Tension-type headacheLi-Ling Hope Pan, Yu-Hsiang Ling, Shuu-Jiun Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 10, 2022
Impact on follow-up strategies in patients with primary sclerosing cholangitisAnnika Bergquist, Tobias J Weismüller, Cynthia Levy, et al.
Journal of Autoimmunity|September 11, 2022
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitisCumali Efe, Koray Taşçılar, Alessio Gerussi, et al.
Journal of Hepatology|July 1, 2022
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitisChristophe Corpechot, Fabrice Carrat, Farid Gaouar, et al.
JHEP Reports : Innovation in Hepatology|October 9, 2024
Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitisSurain B Roberts, Woo Jin Choi, Lawrence Worobetz, et al.
Hepatology (Baltimore, Md.)|May 14, 2022
Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcomeCumali Efe, Anand V Kulkarni, Benedetta Terziroli Beretta-Piccoli, et al.
Journal of Hepatology|May 31, 2024
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantationAldo J Montano-Loza, Ellina Lytvyak, Gideon Hirschfield, et al.
Pageof 7